From the advent of penicillin to anti-cholesterol treatments, history has witnessed major developments in medicine and therapeutic offerings. At the same time, however, the prevalence of both lifestyle and chronic diseases continues to rise
Read More
The U.S., Japan and Eurozone remain the key markets for most companies, but the increasing focus on cost effectiveness and the difficulties of the general economy, make the potential for significant growth in these markets questionable. In contrast, emerging pharmaceutical markets have been growing in the double-digits and are expected to continue expanding in the years ahead, due to strong economic growth, demographic changes, and improved funding for health care.
Read More
Most of our work in health care involves new research and our approach to it always involves more than just one stakeholder, taking several stakeholders in the specific disease ecology into account. In our experience, it is through understanding different stakeholders’ perspectives that new insights can be found and new solutions developed thereafter.
Read More
Although a concern for healthcare systems for several decades, 2013 was a watershed year for obesity. Its recognition as a disease by the American Medical Association provides an opportunity to move beyond dead-end debates around personal responsibility and create renewed focus on what healthcare systems can do to treat this burgeoning epidemic.
Read More
Pharmaceutical companies should begin to take a closer look at how they create the most value for their multiple stakeholders. In the emerging world of value-based health care, the answer will increasingly go beyond a new drug.
Read More
Economic change in China will move hundreds of millions of households from poverty to prosperity. But what does everyday life look like for a Chinese family? One of our ethnographers shares some intimate experiences from a meeting with a middle-class man who has lived through the country’s enormous transformation.
Read More
If Facebook is serious about becoming the social index for the entire web, it needs to do more not to just export social networking functionality but to make Facebook itself a more hospitable place for outside web page content to live.
Read More
Over the course of 14 projects in 5 years, ReD has been responsible for helping set in motion, and for strengthening, Novo Nordisk’s commitment to the needs of diabetes patients.
Read More
ReD helped Samsung develop their own distinct visual design philosophy–one that gave up the aesthetics of technology to instead reflect the aesthetics of the home.
Read More